Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Protalix BioTherapeutics (PLX) Receivables - Other (2019)

Historic Receivables - Other for Protalix BioTherapeutics (PLX) over the last 7 years, with Q4 2019 value amounting to $26000.0.

  • Protalix BioTherapeutics' Receivables - Other changed N/A to $26000.0 in Q4 2019 from the same period last year, while for Dec 2019 it was $26000.0, marking a year-over-year change of. This contributed to the annual value of $26000.0 for FY2019, which is N/A changed from last year.
  • According to the latest figures from Q4 2019, Protalix BioTherapeutics' Receivables - Other is $26000.0.
  • Over the past 5 years, Protalix BioTherapeutics' Receivables - Other peaked at $26000.0 during Q4 2019, and registered a low of $26000.0 during Q4 2019.